Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from captive snakes

Folia Microbiologica

Volumn 55, Issue 1, 2010, Pages 83-87

  Hejnar, P ^a   Kolar M ^a   Sauer, P ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

SERPENTES; STENOTROPHOMONAS MALTOPHILIA;

EID: 77949879782     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-010-0014-9     Document Type: Article

References (19)

1. Berg G., Roskot N., Smalla K.: Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J. Clin. Microbiol. 37, 3594-3600 (1999).
2. Berg G., Eberl L., Hartmann A.: The rhizosphere as a reservoir for opportunistic human pathogenic bacteria. Environ. Microbiol. 7, 1673-1685 (2005).
3. Cérémonie H., Buret F., Simonet P., Vogel T. M.: Isolation of lightning-competent soil bacteria. Appl. Environ. Microbiol. 70, 6342-6346 (2004).
4. CLSI (Clinical and Laboratory Standards Institute): Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S19. Clinical and Laboratory Standards Institute, Wayne (PA, USA) 2009.
5. Denton M., Kerr K. G.: Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11, 57-80 (1998).
6. di Bonaventura G., Stepanovic S., Picciani C., Pompilio A., Piccolomini R.: Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates. Folia Microbiol. 52, 86-90 (2007).
7. Draper C. S., Walker R. D., Lawler H. E.: Patterns of oral bacterial infection in captive snakes. J. Am. Vet. Med. Assoc. 179, 1223-1226 (1981).
8. Elting L. S., Khardori N., Bodey G. P., Fainstein V.: Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect. Control Hosp. Epidemiol. 11, 134-138 (1990).
9. Gould V. C., Okazaki A., Avison M. B.: β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57, 199-203 (2006).
10. Hejnar P., Hamal P., Koukalová D.: Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains. Microbiologica (New Microbiol.)23, 415-421 (2000).
11. Hejnar P., Kolář M., Hájek V., Koukalová D., Hamal P.: Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains. Folia Microbiol. 46, 151-155 (2001).
12. Hejnar P., Chmela Z., Rypka M.: Fatty acid analysis of Stenotrophomonas maltophilia clinical strains showing different susceptibility to antibiotics at 30 and 37 °C. Folia Microbiol. 47, 742-746 (2002).
13. Hejnar P., Bardoň J., Sauer P., Kolář M.: Stenotrophomonas maltophilia as a part of normal oral bacterial flora in captive snakes and its susceptibility to antibiotics. Vet. Microbiol. 121, 357-362 (2007).
14. Khardori N., Elting L., Wong E., Schable B., Bodey G. P.: Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev. Infect. Dis. 12, 997-1003 (1990).
15. Mary P., Defives C., Hornez J. P.: Occurrence and multiple antibiotic resistance profiles of non-fermentative Gram-negative microflora in five brands of non-carbonated French bottled spring water. Microb. Ecol. 39, 322-329 (2000).
16. Pankuch G. A., Jacobs M. R., Rittenhouse S. F., Appelbaum P. C.: Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob. Agents Chemother. 38, 2317-2322 (1994).
17. Papapetropoulou M., Iliopoulou J., Rodopoulou G., Detorakis J., Paniara O.: Occurrence and antibiotic resistance of Pseudomonas species isolated from drinking water in southern Greece. J. Chemother. 6, 111-116 (1994).
18. Wilkinson F. H., Kerr K. G.: Bottled water as a source of multi-resistant Stenotrophomonas and Pseudomonas species for neutropenic patients. Eur. J. Cancer Care7, 12-14 (1998).
19. Wüst J., Frei R., Gunthard H., Altwegg M.: Analysis of restriction fragment length polymorphism and ribotyping of multiresistant Stenotrophomonas maltophilia isolated from persisting lung infection in a cystic fibrosis patient. Scand. J. Infect. Dis. 27, 499-502 (1995).